methylprednisolone has been researched along with Malignant Carcinoid Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GEFFROY, Y | 1 |
Dudley, CR; Glover, S; Parry, RG | 1 |
May, B | 1 |
1 review(s) available for methylprednisolone and Malignant Carcinoid Syndrome
Article | Year |
---|---|
[Carcinoid: diagnosis and therapy].
Topics: Aprotinin; Bradykinin; Carcinoid Heart Disease; Carcinoid Tumor; Cyproheptadine; Diagnosis, Differential; Ergot Alkaloids; Humans; Hydroxyindoleacetic Acid; Kallidin; Malignant Carcinoid Syndrome; Methylprednisolone; Methysergide; Phentolamine; Pizotyline; Serotonin | 1975 |
2 other study(ies) available for methylprednisolone and Malignant Carcinoid Syndrome
Article | Year |
---|---|
[THE CARCINOID SYNDROME (APROPOS OF 7 CASES)].
Topics: Geriatrics; Growth Hormone; Humans; Hydroxyindoleacetic Acid; Indoleacetic Acids; Malignant Carcinoid Syndrome; Methyldopa; Methylprednisolone; Pituitary Irradiation; Selective Serotonin Reuptake Inhibitors; Serotonin; Skin Manifestations; Therapeutics; Vasomotor System; Yttrium Isotopes | 1964 |
Acute renal failure associated with carcinoid crisis.
Topics: Acute Kidney Injury; Antineoplastic Agents, Hormonal; Creatinine; Fatal Outcome; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Methylprednisolone; Middle Aged; Octreotide | 1996 |